These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25176123)

  • 21. Predicting abuse potential of stimulants and other dopaminergic drugs: overview and recommendations.
    Huskinson SL; Naylor JE; Rowlett JK; Freeman KB
    Neuropharmacology; 2014 Dec; 87():66-80. PubMed ID: 24662599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A proactive nonclinical drug abuse and dependence liability assessment strategy: a sponsor perspective.
    Swedberg MD
    Behav Pharmacol; 2013 Sep; 24(5-6):396-402. PubMed ID: 23907375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures.
    Mello NK; Negus SS
    Neuropsychopharmacology; 1996 Jun; 14(6):375-424. PubMed ID: 8726752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The utility of the zebrafish model in conditioned place preference to assess the rewarding effects of drugs.
    Collier AD; Echevarria DJ
    Behav Pharmacol; 2013 Sep; 24(5-6):375-83. PubMed ID: 23811781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Addictive potential in man: methodological aspects].
    Warot D; Marra D
    Therapie; 1995; 50(6):531-6. PubMed ID: 8745952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Caffeine as a model drug of dependence: recent developments in understanding caffeine withdrawal, the caffeine dependence syndrome, and caffeine negative reinforcement.
    Griffiths RR; Chausmer AL
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 Nov; 20(5):223-31. PubMed ID: 11326548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Training the next generation of providers in addiction medicine.
    Rasyidi E; Wilkins JN; Danovitch I
    Psychiatr Clin North Am; 2012 Jun; 35(2):461-80. PubMed ID: 22640766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A translational pharmacology approach to understanding the predictive value of abuse potential assessments.
    Horton DB; Potter DM; Mead AN
    Behav Pharmacol; 2013 Sep; 24(5-6):410-36. PubMed ID: 23873088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zebrafish models to study drug abuse-related phenotypes.
    Stewart A; Wong K; Cachat J; Gaikwad S; Kyzar E; Wu N; Hart P; Piet V; Utterback E; Elegante M; Tien D; Kalueff AV
    Rev Neurosci; 2011; 22(1):95-105. PubMed ID: 21615264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating the abuse potential of psychedelic drugs as part of the safety pharmacology assessment for medical use in humans.
    Heal DJ; Gosden J; Smith SL
    Neuropharmacology; 2018 Nov; 142():89-115. PubMed ID: 29427652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Animal models for opioid addiction drug discovery.
    Grenald SA; Largent-Milnes TM; Vanderah TW
    Expert Opin Drug Discov; 2014 Nov; 9(11):1345-54. PubMed ID: 25307021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug addiction. Part II. Neurobiology of addiction.
    Vetulani J
    Pol J Pharmacol; 2001; 53(4):303-17. PubMed ID: 11990077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The gold-standard in preclinical abuse liability testing: It's all relative.
    Gauvin DV; Zimmermann ZJ; Baird TJ
    J Pharmacol Toxicol Methods; 2018; 94(Pt 2):36-53. PubMed ID: 30125620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug addiction, dysregulation of reward, and allostasis.
    Koob GF; Le Moal M
    Neuropsychopharmacology; 2001 Feb; 24(2):97-129. PubMed ID: 11120394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computational approaches to the neurobiology of drug addiction.
    Ahmed SH; Graupner M; Gutkin B
    Pharmacopsychiatry; 2009 May; 42 Suppl 1():S144-52. PubMed ID: 19434552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The psychopharmacology of narcotics: a preclinical study].
    Evartau EE
    Eksp Klin Farmakol; 1992; 55(5):65-8. PubMed ID: 1305461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The predictive validity of the rat self-administration model for abuse liability.
    O'Connor EC; Chapman K; Butler P; Mead AN
    Neurosci Biobehav Rev; 2011 Jan; 35(3):912-38. PubMed ID: 21036191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug dependence studies in laboratory animals.
    Yanagita T
    NIDA Res Monogr; 1978; (19):179-90. PubMed ID: 106285
    [No Abstract]   [Full Text] [Related]  

  • 39. Abuse potential evaluation of inhalants.
    Balster RL
    Drug Alcohol Depend; 1987 Jan; 19(1):7-15. PubMed ID: 3102196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of the limbic system in dependence on drugs.
    Rodríguez de Fonseca F; Navarro M
    Ann Med; 1998 Aug; 30(4):397-405. PubMed ID: 9783839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.